A new analysis commissioned by Sen. Bernie Sanders, shows U.S. consumers and insurers pay two to four times more for prescription drugs than other rich countries.
The Defender is experiencing censorship on many social channels. Be sure to stay in touch with the news that matters by subscribing to our top news of the day. It’s free.
A new government study commissioned by Sen. Bernie Sanders shows that the U.S. pays two to four times more for prescription drugs than other rich countries, a finding that came as President Joe Biden rolled out a social safety-net plan on Wednesday that excludes progressive proposals to tackle sky-high medicine costs.
According to an analysis by the Government Accountability Office (GAO), retail prices that U.S. consumers and insurers paid for 20 brand-name prescription drugs in 2020 were 2.82 times higher than in Canada, 4.25 times higher than in Australia, and 4.36 times higher than in France.
The drugs GAO examined were a sampling of 41 brand-name medicines with the highest expenditures and use in the Medicare Part D program, which under current federal law is prohibited from negotiating prices with pharmaceutical companies.
One example GAO cites is Xarelto, a blood clot medication that costs more than $558 for 30 tablets in the U.S. but just over $85 in Canada.
Read full story here: https://childrenshealthdefense.org/defender/big-pharma-ripping-off-u-s-consumers/?utm_source=salsa&eType=EmailBlastContent&eId=6c195508-d790-4cb1-b562-47b578dd9577